Aclaris Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 65.2M |
| FY2023 | 69.8M |
| FY2024 | 77.3M |
| FY2025 | 122.6M |
| FY2026 | 120.6M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 65.2M |
| FY2023 | 69.8M |
| FY2024 | 77.3M |
| FY2025 | 122.6M |
| FY2026 | 120.6M |